Co-Authors
This is a "connection" page, showing publications co-authored by Everardo Cobos and Murali Yallapu.
Connection Strength
0.288
-
Nayek U, Sharma T, Kashyap VK, Gadad S, Yallapu MM, Cobos E, Chauhan SC. Scope of nanobodies in hepatopancreatobiliary oncology. Drug Discov Today. 2026 Apr 10; 31(3):104666.
Score: 0.062
-
Kashyap VK, Sharma BP, Singh HN, Kumar S, Verma D, Parashar D, Yallapu MM, Cobos E, Chauhan SC. Bioinformatics analysis of TRPV1 expression and its role in hepatocellular carcinoma prognosis. Discov Oncol. 2026 Mar 27; 17(1).
Score: 0.062
-
Kashyap VK, Kenchappa DB, Singh AK, Singh B, Yallapu MM, Cobos E, Chauhan SC. Alcohol Consumption and Cervical Carcinogenesis: Time to Draw Conclusions. Cells. 2025 Oct 21; 14(20).
Score: 0.060
-
Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, Cobos E, Yallapu MM, Jaggi M, Chauhan SC. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer Metastasis Rev. 2024 Sep; 43(3):981-999.
Score: 0.054
-
Dhasmana A, Dhasmana S, Haque S, Cobos E, Yallapu MM, Chauhan SC. Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics. Cancer Metastasis Rev. 2023 09; 42(3):597-600.
Score: 0.052